GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats.
GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.
GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
GHTC condemns President Trump’s fiscal year 2021 budget request seeking deep cuts to global health and medical research programs. The budget proposes a 34 percent cut to global health programs at the US Agency for International Development and the State Department, as well as significant cuts to public health and research agencies within the Department of Health and Human Services.
Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.
The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.
Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.
GHTC's US Policy Officer Emily Conron spoke with Healio Infectious Disease News about the disastrous impact the President's proposed budget cuts could have on global health R&D.
Devex featured an op-ed from GHTC's Director Jamie Bay Nishi making a case that to achieve healthy lives for all, we need a "one-two punch" of innovation and access.
Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).
A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill.
GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats.
GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.
GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
